Analysis of TCGA data via cBioPortal revealed a low mutation frequency of LSM2 in gliomas (0% in LGG, 5% in GBM, predominantly amplifications/deletions) (Figures 4A, B). The gene discussed is LSM2; the disease is central nervous system cancer.